Study Information
| Title: | Phase II of Carbo/Pralatrexate in Rec. Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer  |
| Status: | Recruiting participants |
| Conditions: | Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer |
| Interventions: | Drug: carboplatin; Drug: pralatrexate |
| Institutions: | Brigham and Women's Hospital, Dana-Farber Cancer Institute, Massachusetts General Hospital |
| Health Topics: | Fallopian Tube Cancer, Ovarian Cancer |
Contact Information
Dana-Farber Cancer Institute
Boston, MA 02115
Massachusetts General Hospital
Boston, MA 02114